Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 58:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004095 AN006788 Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics Cultured cells Human Cancer Amgen LC-MS
ST003702 AN006074 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO Liver Mouse University of Bonn LC-MS
ST003614 AN005939 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion Liver Mouse University of Bonn LC-MS
ST003522 AN005784 Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice Adipose tissue Mouse Cancer Stanford University LC-MS
ST003522 AN005784 Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice Tumor tissue Mouse Cancer Stanford University LC-MS
ST003293 AN005392 High Fat Feeding Alters Circulating Triglyceride Profile by Decreasing SCD Activity and Depleting omega-3 Fatty Acids Blood Rat Hyperlipidemia University of Southern California LC-MS
ST003090 AN005054 Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B Cultured cells Mouse Rutgers University LC-MS
ST003051 AN005002 Shotgun lipidomics of breast cancer endocrine therapy persisters Breast cancer cells Human Cancer Dartmouth College LC-MS
ST002843 AN004653 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) Liver Mouse Cancer Rutgers University LC-MS
ST002842 AN004651 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) Liver Mouse Cancer Rutgers University LC-MS
ST002817 AN004584 Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics Heart Mouse Cardiomyopathy University of California, San Francisco LC-MS
ST002764 AN004499 Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort Blood Human Cancer Icahn School of Medicine at Mount Sinai LC-MS
ST002729 AN004426 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Muscle Mouse Diabetes Medical Institute of Bioregulation, Kyushu University LC-MS
ST002700 AN004376 Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics Blood Human Autism Columbia University LC-MS
ST002438 AN003972 Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice Lung Mouse Asthma University of California, Davis LC-MS
ST002422 AN003944 UBXD8 lipidomics from whole cells (Part 2) Cultured cells Human University of Arizona LC-MS
ST002421 AN003942 UBXD8 lipidomics from whole cells (Part 1) Cultured cells Human University of Arizona LC-MS
ST002070 AN003374 Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Cultured cells Human Cancer Ohio State University LC-MS
ST001989 AN003241 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) LNCaP cells Human Cancer IGMM LC-MS
ST001988 AN003240 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 2) LNCaP cells Human Cancer IGMM LC-MS
ST001949 AN003173 Plasma Metabolome Normalization in Rheumatoid Arthritis following initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy Blood Human Rheumatoid arthritis University of Kansas GC-MS
ST001815 AN002946 Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis Blood Human Arthritis University of Kansas GC-MS/LC-MS
ST001632 AN002668 Lipidomics of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat Blood Rat Ischemia Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College LC-MS
ST001632 AN002668 Lipidomics of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat Heart Rat Ischemia Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College LC-MS
ST001451 AN002426 Eleostearic acid effects on TAGs and oxLipids Breast cancer cells Human Cancer Fox Chase Cancer Center LC-MS
ST001292 AN002149 Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. Kidney Mouse Diabetes University of Michigan LC-MS
ST001211 AN002018 Metabolomic Markers of Methotrexate Response, In Vitro Cultured cells Human University of Kansas GC-MS/LC-MS
ST000991 AN001617 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) Blood Human University of California, Davis LC-MS
ST000990 AN001616 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) Blood Human University of California, Davis LC-MS
ST000988 AN001614 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) Blood Human University of California, Davis LC-MS
ST000985 AN001611 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) Blood Human University of California, Davis LC-MS
ST000984 AN001610 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) Blood Human University of California, Davis LC-MS
ST000983 AN001609 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) Blood Human University of California, Davis LC-MS
ST000915 AN001488 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000842 AN001359 Muscle and plasma before and after exercise Blood Human Obesity University of Michigan LC-MS
ST000780 AN001235 High fat diet and sciatic nerves functions Blood Mouse Neuropathy University of Michigan LC-MS
ST000777 AN001229 Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study) preliminary data Adipose tissue Human Obesity University of Michigan LC-MS
ST000775 AN001225 Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study Blood Human Depression University of Michigan LC-MS
ST000673 AN001033 Lipidomics in (SIDS) Sudden Infant Death Syndrome Blood Human Sudden infant death syndrome University of Michigan LC-MS
ST000672 AN001031 Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison (part II) Blood Mouse Diabetes University of Michigan LC-MS
ST000670 AN001027 Exposure to high fat diets and bisphenol Blood Mouse University of Michigan LC-MS
ST000668 AN001023 Diet manipulation on the lipidome Blood Human University of Michigan LC-MS
ST000665 AN001017 Nonalcoholic fatty liver disease (NAFLD) Studies Cultured cells Human Fatty liver disease University of Michigan LC-MS
ST000664 AN001015 Nutritional Psychiatric Illness Studies Blood Human Bipolar I Disorder University of Michigan LC-MS
ST000662 AN001011 Lipidomics of hormone-sensitive lipase variants Adipose tissue Human University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Human Obesity University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Rat Obesity University of Michigan LC-MS
ST000005 AN000012 Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin Macrophages Mouse LIPID MAPS GC-MS/LC-MS
  logo